UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Nature communications, 2018-11, Vol.9 (1), p.4664-5, Article 4664

2018

Volltextzugriff (PDF)

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.81-89

2021

Volltextzugriff (PDF)

Molecular sputum analysis for the diagnosis of lung cancer

British journal of cancer, 2013-08, Vol.109 (3), p.530-537

2013

Volltextzugriff (PDF)

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S91-S92

Thunnissen, E.

2021

Volltextzugriff (PDF)

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

Lung cancer (Amsterdam, Netherlands), 2019-12, Vol.138, p.102-108

2019

Volltextzugriff (PDF)

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S985-S985

2021

Volltextzugriff (PDF)

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

Annals of oncology, 2012-12, Vol.23 (12), p.3188-3189

2012

Volltextzugriff (PDF)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

British journal of cancer, 2014-07, Vol.111 (2), p.413-420

2014

Volltextzugriff (PDF)

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1633-S1634

Thunnissen, E.

2017

Volltextzugriff (PDF)

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii49-viii49

2018

Volltextzugriff (PDF)

Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2016-08, Vol.98, p.118-121

2016

Volltextzugriff (PDF)

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S325-S325

2018

Volltextzugriff (PDF)

High-dose, weekly erlotinib is not an effective treatment in EGFR -mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib

European journal of cancer (1990), 2014-05, Vol.50 (7), p.1399-1401

2014

Volltextzugriff (PDF)

22O REBIOPSY IN TKI-RESISTANCE: A RETROSPECTIVE ANALYSIS

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S10-S10

2013

Volltextzugriff (PDF)

3001 Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project

European journal of cancer (1990), 2015-09, Vol.51, p.S595-S596

2015

Volltextzugriff (PDF)

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S87-S88

2022

Volltextzugriff (PDF)

Guidance for laboratories performing molecular pathology for cancer patients

Journal of clinical pathology, 2014-11, Vol.67 (11), p.923-931

2014

Volltextzugriff (PDF)

15O VOLUMETRIC COMPUTER TOMOGRAPHY SCREENING FOR LUNG CANCER: THREE ROUNDS OF THE NELSON TRIAL

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S7-S7

2013

Volltextzugriff (PDF)

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.985-989

2015

Volltextzugriff (PDF)

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

Lung cancer (Amsterdam, Netherlands), 2012-04, Vol.76 (1), p.1-18

2012

Volltextzugriff (PDF)

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

Virchows Archiv : an international journal of pathology, 2012-09, Vol.461 (3), p.245-257

2012

Volltextzugriff (PDF)

Results of a Pilot External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small Cell Lung Cancer Managed by EMQN, ESMO, ESP, and ETOP

European journal of cancer (1990), 2011, Vol.47, p.13-13

2011

Volltextzugriff (PDF)

ETOP activity in the field of biomarkers and predictors

Lung cancer (Amsterdam, Netherlands), 2012-06, Vol.77, p.S16-S17

2012

Volltextzugriff (PDF)

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S971-S971

2021

Volltextzugriff (PDF)

PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily Practice

Value in health, 2011, Vol.14 (7), p.A463-A464

2011

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Molecular sputum analysis for the diagnosis of lung cancer

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

High-dose, weekly erlotinib is not an effective treatment in EGFR -mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib

22O REBIOPSY IN TKI-RESISTANCE: A RETROSPECTIVE ANALYSIS

3001 Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

Guidance for laboratories performing molecular pathology for cancer patients

15O VOLUMETRIC COMPUTER TOMOGRAPHY SCREENING FOR LUNG CANCER: THREE ROUNDS OF THE NELSON TRIAL

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

Results of a Pilot External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small Cell Lung Cancer Managed by EMQN, ESMO, ESP, and ETOP

ETOP activity in the field of biomarkers and predictors

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily Practice

Aktive Filter

Suchergebnisse filtern